Literature DB >> 24941371

NK cell phenotypic and functional heterogeneities and molecular mechanisms of cytotoxicity.

Benjamin Bonavida1.   

Abstract

Natural killer (NK) cells were discovered four decades ago, independently, by the Kiessling and Herberman groups. Since then, significant advances have accrued regarding the functional and molecular properties of NK cells as well as their clinical relevance. The important feature of NK cells is their inability to kill normal cells, while they are highly cytotoxic for infected or transformed cells. This discrimination has been largely resolved by the discovery of both activating and inhibitory receptors on NK cells and corresponding ligands on target cells. This review focuses briefly on several issues related to NK cells: (1) the phenotypic properties of NK cells, (2) the heterogeneity of NK cell activities, (3) the determination of three major NK subsets (Free, Binder, and Killer), (4) the maturation and activation of NK subsets, (5) the response of NK cells to various cytokines, (6) the target-induced inactivation and cell death of NK cells, (7) the multiple mechanisms of cell-mediated cytotoxicity, (8) the characterization of NK cytotoxic factors (NKCF), and (9) the role of membrane fluidity in cytotoxicity. These subjects are described chronologically beginning shortly after the discovery of NK cells as a result of Ron Herberman's leadership, and I am gratefully indebted to him.

Entities:  

Mesh:

Year:  2014        PMID: 24941371     DOI: 10.1615/critrevoncog.2014010804

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  3 in total

1.  Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.

Authors:  Chandan Verma; Viriya Kaewkangsadan; Jennifer M Eremin; Gerard P Cowley; Mohammad Ilyas; Mohamed A El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2015-06-04       Impact factor: 5.531

2.  Nodal Epstein-Barr virus-positive T-cell/NK-cell lymphoma associated with immunodeficiency: a rare condition looking for recognition.

Authors:  Cristiane Rúbia Ferreira; Aloísio Felipe-Silva; Fernando Peixoto Ferraz de Campos; Maria Cláudia Nogueira Zerbini
Journal:  Autops Case Rep       Date:  2014-03-30

3.  Immunotherapy utilizing the combination of natural killer- and antibody dependent cellular cytotoxicity (ADCC)-mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition.

Authors:  Kathleen E Fenerty; Michelle Padget; Benjamin Wolfson; Sofia R Gameiro; Zhen Su; John H Lee; Shahrooz Rabizadeh; Patrick Soon-Shiong; James W Hodge
Journal:  J Immunother Cancer       Date:  2018-11-29       Impact factor: 13.751

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.